Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases.
Del Álamo M, Bührer C, Fisher D, Griese M, Lingor P, Palladini G, Sireau N, Hivert V, Sangiorgi L, Guillot F, Halftermeyer J, Soucková L, Nosková K, Demlová R. Del Álamo M, et al. Among authors: noskova k. Trials. 2022 Sep 15;23(1):783. doi: 10.1186/s13063-022-06713-y. Trials. 2022. PMID: 36109818 Free PMC article.
Bile acids, nuclear receptors and cytochrome P450.
Juřica J, Dovrtělová G, Nosková K, Zendulka O. Juřica J, et al. Among authors: noskova k. Physiol Res. 2016 Dec 21;65(Suppl 4):S427-S440. doi: 10.33549/physiolres.933512. Physiol Res. 2016. PMID: 28006925 Free article. Review.
Cannabinoids and Cytochrome P450 Interactions.
Zendulka O, Dovrtělová G, Nosková K, Turjap M, Šulcová A, Hanuš L, Juřica J. Zendulka O, et al. Among authors: noskova k. Curr Drug Metab. 2016;17(3):206-26. doi: 10.2174/1389200217666151210142051. Curr Drug Metab. 2016. PMID: 26651971 Review.
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.
Pokorna P, Lakka Klement G, Vasikova A, Kanderova V, Jezova M, Noskova K, Mudry P, Kyr M, Merta T, Bajciova V, Krenova Z, Palova H, Valik D, Zdrazilova Dubska L, Slaby O, Sterba J. Pokorna P, et al. Among authors: noskova k. JCO Precis Oncol. 2022 Jun;6:e2100525. doi: 10.1200/PO.21.00525. JCO Precis Oncol. 2022. PMID: 35700412 Free PMC article. No abstract available.
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.
Palova H, Das A, Pokorna P, Bajciova V, Pavelka Z, Jezova M, Pal K, Dimayacyac JR, Negm L, Stengs L, Bianchi V, Vejmelkova K, Noskova K, Jarosova M, Mejstrikova S, Mudry P, Kyr M, Merta T, Tinka P, Drabova K, Aulicka S, Jugas R, Tabori U, Slaby O, Sterba J. Palova H, et al. Among authors: noskova k. NPJ Precis Oncol. 2024 May 21;8(1):110. doi: 10.1038/s41698-024-00597-8. NPJ Precis Oncol. 2024. PMID: 38773265 Free PMC article.
34 results